QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: How to Read and Cite EU Pharmaceutical Legislation

Test your understanding of the concepts covered by How to Read and Cite EU Pharmaceutical Legislation: Regulations, Directives, Decisions and Guidance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A pharmacovigilance committee concludes that new evidence changes the benefit-risk balance. Which statement best describes the relationship between that conclusion and a legal obligation?
Question 2 of 10 Which combination best describes the complementary roles of EUR-Lex and EudraLex?
Question 3 of 10 A company follows an alternative approach to a guideline. Which documentation would best support a defensible assessment?
Question 4 of 10 A provision refers to a technical requirement contained in an annex. What is the best citation practice?
Question 5 of 10 A provision uses the term marketing authorisation, and the team interprets it according to ordinary commercial usage without checking definitions. What is the principal risk?
Question 6 of 10 What is the main reason a retrieval date should be recorded for web-based regulatory sources?
Question 7 of 10 A company relies on Directive 2001/83/EC to determine the exact administrative form required by a national competent authority. What is the most appropriate interpretation?
Question 8 of 10 What is the most appropriate use of a search engine in regulatory research?
Question 9 of 10 A referral occurred in 2018, but the relevant legal provision was substantially amended in 2023. Which source approach is most appropriate for reconstructing the historical legal position?
Question 10 of 10 What is the defining purpose of a delegated act under Article 290 TFEU?

Select an answer to continue.